Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of Aβpeptides of Alzheimer's disease

被引:111
作者
Kuo, YM
Webster, S
Emmerling, MR
De Lima, N
Roher, AE
机构
[1] Sun Hlth Res Inst, Haldeman Lab Alzheimer Dis Res, Sun City, AZ 85351 USA
[2] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA
[3] Parke Davis, Ann Arbor, MI 48106 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1998年 / 1406卷 / 03期
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; A beta; dimerization/tetramerization; proteolytic resistance; fibrillogenesis;
D O I
10.1016/S0925-4439(98)00014-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Experimental evidence increasingly implicates the beta-amyloid peptide in the pathogenesis of Alzheimer's disease. beta-amyloid filaments dramatically accumulate in the neuritic plaques and vascular deposits as the result of the brain's inability to clear these structures. In this paper, we demonstrate that in addition to the intrinsic stability of A beta N-42, the time dependent generation of irreversibly associated AP dimers and tetramers incorporated into A beta filaments are themselves resistant to proteolytic degradation. The presence of post-translational modifications such as isomerization of aspartyls 1 and 7, cyclization of glutamyl 3 to pyroglutamyl and oxidation of methionyl 35, further contribute to the insolubility and stability of A beta. All these factors promote the accumulation of neurotoxic amyloid in the brains of patients with Alzheimer's disease, and should be considered in therapeutic strategies directed towards the dissociation of the brain's A beta filaments. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 26 条
[1]  
CHANEY MO, 1997, UNPUB PROTEIN ENG
[2]   PH-DEPENDENT STRUCTURAL TRANSITIONS OF ALZHEIMER AMYLOID PEPTIDES [J].
FRASER, PE ;
NGUYEN, JT ;
SUREWICZ, WK ;
KIRSCHNER, DA .
BIOPHYSICAL JOURNAL, 1991, 60 (05) :1190-1201
[3]   Soluble amyloid A beta-(1-40) exists as a stable dimer at low concentrations [J].
GarzonRodriguez, W ;
SepulvedaBecerra, M ;
Milton, S ;
Glabe, CG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21037-21044
[4]  
Giulian D, 1996, J NEUROSCI, V16, P6021
[5]   10 TO 14 RESIDUE PEPTIDES OF ALZHEIMERS-DISEASE PROTEIN ARE SUFFICIENT FOR AMYLOID FIBRIL FORMATION AND ITS CHARACTERISTIC X-RAY-DIFFRACTION PATTERN [J].
GOREVIC, PD ;
CASTANO, EM ;
SARMA, R ;
FRANGIONE, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 147 (02) :854-862
[6]  
GOWING E, 1994, J BIOL CHEM, V269, P10987
[7]   AGGREGATION AND SECONDARY STRUCTURE OF SYNTHETIC AMYLOID BETA-A4 PEPTIDES OF ALZHEIMERS-DISEASE [J].
HILBICH, C ;
KISTERSWOIKE, B ;
REED, J ;
MASTERS, CL ;
BEYREUTHER, K .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (01) :149-163
[8]   The immunoreactive profile at the N-terminal region of A beta 1-39/40 but not A beta 1-42 changes with transition from monomer dimer to further peptide aggregates [J].
Kametani, F ;
Tanaka, K ;
Tokuda, T ;
Allsop, D .
BRAIN RESEARCH, 1995, 703 (1-2) :237-241
[9]   Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits [J].
Kuo, YM ;
Emmerling, MR ;
Woods, AS ;
Cotter, RJ ;
Roher, AE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (01) :188-191
[10]  
Kuo YM, 1996, J BIOL CHEM, V271, P4077